ORIGINAL RESEARCH article
Front. Nutr.
Sec. Nutrition and Microbes
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1573636
This article is part of the Research TopicHarnessing the Potential of Functional Foods Containing Bioactive Compounds: Implications for Health and SustainabilityView all 4 articles
Association of Gut Microbiota Dietary Index With Metabolic Dysfunction-Associated Steatotic Liver Disease: The Mediating Roles of Inflammation and Body Mass Index
Provisionally accepted
- Renmin Hospital of Wuhan University, Wuhan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background The gut microbiota plays a significant role in the progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). The recently introduced Dietary Index of Gut Microbiota (DI-GM), which reflects the diversity of the gut microbiota, has yet to be investigated in relation to MASLD.Methods This analysis used raw data from the National Health and Nutrition Examination Survey (2001-2018). MASLD was identified using the US-Fatty Liver Index (US-FLI), and dietary recall data were applied to calculate the Dietary Index of Gut Microbiota (DI-GM). Weighted multivariate logistic regression models assessed the relationship between DI-GM and MASLD. Additionally, mediation analysis was performed to evaluate the influence of high-sensitivity C-reactive protein (hs-CRP) and body mass index (BMI) on the relationship between DI-GM and MAFLD. Propensity score matching (PSM) was employed to minimize confounding and reduce bias inherent to observational studies.Results A total of 3,473 participants were included in the analysis, among whom 1,247 were diagnosed with MASLD, with a weighted prevalence of 35.90%. After adjusting for demographic, lifestyle, and metabolic syndrome-related variables, a higher score of DI-GM was strongly linked to a lower risk of MASLD (OR=0.90, 95% CI: 0.85-0.95, p<0.001). Mediation analysis estimated that BMI accounted for 59.47% of the association (p<0.001), while hs-CRP explained 15.68%. Even after PSM, a higher score of DI-GM remained significantly associated with a lower incidence of MASLD.Conclusions The newly proposed DI-GM demonstrated a notable negative correlation with the prevalence of MASLD. Mediation analyses revealed that this relationship was largely influenced by BMI and hs-CRP, highlighting their critical mediating roles.
Keywords: DI-GM, MASLD, Hs-CRP, BMI, •NHANES
Received: 09 Feb 2025; Accepted: 29 Apr 2025.
Copyright: © 2025 Pu, Tan, Wu, Zeng, He, Zhang and Dong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Weiguo Dong, Renmin Hospital of Wuhan University, Wuhan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.